All Stories

  1. Curcumin-QingDai Combination as Treatment for Moderate-Severe Ulcerative Colitis

    Article • Case Reports in Gastroenterology, September 2022, Karger Publishers

    Shomron Ben-Horin

  2. CT-P13: a review on a biosimilar to infliximab in the treatment of inflammatory bowel disease

    Article • Expert Opinion on Biological Therapy, August 2019, Taylor & Francis

    Shomron Ben-Horin

  3. Development and validation of novel algorithms to identify patients with inflammatory bowel diseases in Israel: an epi-IIRN group study

    Article • Clinical Epidemiology, June 2018, Dove Medical Press

    Dr Moshe B Hoshen, Shomron Ben-Horin

  4. Over-reaching beyond disease activity: the influence of anxiety and medical economic burden on health-related quality of life in patients with inflammatory bowel disease

    Article • Patient Preference and Adherence, December 2016, Dove Medical Press

    Shomron Ben-Horin

  5. Magnetic resonance enterography or video capsule endoscopy – what do Crohn’s disease patients prefer?

    Article • Patient Preference and Adherence, June 2016, Dove Medical Press

    Dr Henit Yanai, Shomron Ben-Horin

  6. Rarity of adenomatous polyps in ulcerative colitis and its implications for colonic carcinogenesis

    Article • Endoscopy, October 2015, Thieme Publishing Group

    Shomron Ben-Horin

  7. Ashkenazi Jewish Origin Protects Against Formation of Antibodies to Infliximab and Therapy Failure

    Article • Medicine, May 2015, Wolters Kluwer Health

    Shomron Ben-Horin

  8. Partners of patients with inflammatory bowel disease: how important is their support?

    Article • Clinical and Experimental Gastroenterology, July 2014, Taylor & Francis

    Shomron Ben-Horin